Total Payments
$162,438
2024 Payments
$29,422
Companies
21
Transactions
324
Medicare Patients
984
Medicare Billing
$149,354
Payment Breakdown by Category
Other$78,973 (48.6%)
Consulting$55,127 (33.9%)
Travel$20,570 (12.7%)
Food & Beverage$5,288 (3.3%)
Education$2,480 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65,298 | 23 | 40.2% |
| Consulting Fee | $55,127 | 21 | 33.9% |
| Travel and Lodging | $20,570 | 56 | 12.7% |
| Honoraria | $13,676 | 6 | 8.4% |
| Food and Beverage | $5,288 | 142 | 3.3% |
| Education | $2,480 | 76 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $69,840 | 49 | $0 (2024) |
| Veloxis Pharmaceuticals, Inc. | $53,713 | 79 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $29,149 | 114 | $0 (2024) |
| GENZYME CORPORATION | $8,281 | 8 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $369.33 | 19 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $276.78 | 10 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $188.83 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $100.23 | 5 | $0 (2023) |
| Travere Therapeutics, Inc. | $61.75 | 8 | $0 (2024) |
| Madrigal Pharmaceuticals | $57.76 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,422 | 45 | SANOFI-AVENTIS U.S. LLC ($17,243) |
| 2023 | $25,940 | 46 | SANOFI-AVENTIS U.S. LLC ($19,361) |
| 2022 | $36,810 | 37 | SANOFI-AVENTIS U.S. LLC ($26,000) |
| 2021 | $8,184 | 9 | SANOFI-AVENTIS U.S. LLC ($7,147) |
| 2020 | $12,749 | 22 | Veloxis Pharmaceuticals, Inc. ($10,928) |
| 2019 | $6,733 | 18 | GENZYME CORPORATION ($6,355) |
| 2018 | $16,072 | 29 | Veloxis Pharmaceuticals, Inc. ($12,873) |
| 2017 | $26,527 | 118 | Alexion Pharmaceuticals, Inc. ($26,142) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: TRANSPLANTATION | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,689.00 | General |
| Category: Oncology | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $598.00 | General |
| Category: Oncology | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $541.21 | General |
| Category: Oncology | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $291.96 | General |
| Category: Oncology | ||||||
| 12/11/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $121.30 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,963.00 | General |
| Category: Oncology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $431.89 | General |
| Category: Oncology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $339.37 | General |
| Category: Oncology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $116.02 | General |
| Category: Oncology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $98.23 | General |
| Category: Oncology | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $25.73 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Rare Disease | ||||||
| 11/01/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Consulting Fee | Cash or cash equivalent | $4,025.00 | General |
| Category: TRANSPLANTATION | ||||||
| 10/31/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Rare Disease | ||||||
| 10/26/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Travel and Lodging | In-kind items and services | $527.96 | General |
| Category: TRANSPLANTATION | ||||||
| 10/26/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Travel and Lodging | In-kind items and services | $377.04 | General |
| Category: TRANSPLANTATION | ||||||
| 10/26/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Travel and Lodging | In-kind items and services | $268.62 | General |
| Category: TRANSPLANTATION | ||||||
| 10/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/24/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: TRANSPLANTATION | ||||||
| 09/17/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: TRANSPLANTATION | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU, XIFAXAN | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 200 | 358 | $106,022 | $27,983 |
| 2022 | 5 | 218 | 409 | $128,306 | $31,843 |
| 2021 | 7 | 289 | 599 | $195,255 | $47,691 |
| 2020 | 5 | 277 | 558 | $178,349 | $41,838 |
Total Patients
984
Total Services
1,924
Medicare Billing
$149,354
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 161 | $43,309 | $11,661 | 26.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 109 | $38,695 | $10,257 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 70 | $17,430 | $4,419 | 25.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 18 | $6,588 | $1,646 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 66 | 174 | $61,770 | $14,044 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 101 | 160 | $43,040 | $12,412 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 46 | $11,454 | $2,612 | 22.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $6,552 | $1,511 | 23.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 15 | $5,490 | $1,264 | 23.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 304 | $107,920 | $25,369 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 126 | 182 | $48,958 | $13,239 | 27.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 59 | $14,691 | $3,262 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $6,732 | $1,564 | 23.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $6,552 | $1,538 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 16 | 17 | $6,222 | $1,463 | 23.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 11 | $4,180 | $1,256 | 30.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 76 | 244 | $86,620 | $20,895 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 132 | 189 | $50,841 | $11,156 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 86 | $21,414 | $5,104 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $11,056 | $2,663 | 24.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 23 | 23 | $8,418 | $2,020 | 24.0% |
About Dr. Christina Klein, MD
Dr. Christina Klein, MD is a Nephrology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750428025.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christina Klein, MD has received a total of $162,438 in payments from pharmaceutical and medical device companies, with $29,422 received in 2024. These payments were reported across 324 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($65,298).
As a Medicare-enrolled provider, Klein has provided services to 984 Medicare beneficiaries, totaling 1,924 services with total Medicare billing of $149,354. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Atlanta, GA
- Active Since 01/30/2007
- Last Updated 11/06/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1750428025
Products in Payments
- THYMOGLOBULIN (Biological) $69,219
- SOLIRIS (Drug) $29,042
- Envarsus (Drug) $22,747
- ENVARSUS (Drug) $17,895
- Envarsus XR (SP) (Drug) $12,873
- NO PRODUCT DISCUSSED (Drug) $6,334
- XIFAXAN (Drug) $404.23
- THYMOGLOBULIN (Drug) $233.24
- ACTHAR (Biological) $223.17
- Envarsus XR (Drug) $198.40
- OCALIVA (Drug) $188.83
- ULTOMIRIS (Biological) $105.01
- Cresemba (Drug) $100.23
- TERLIVAZ (Drug) $64.25
- RESMETIROM (Drug) $57.76
- IQIRVO (Drug) $51.81
- M2000 system (Device) $48.91
- TARPEYO (Drug) $37.52
- Viekira (Drug) $29.76
- TEFLARO (Drug) $24.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Atlanta
Sheldon Shore, Md, MD
Nephrology — Payments: $374,918
Nephrology $374,918
Frederic Rahbari Oskoui, Md, MD
Nephrology — Payments: $91,582
Nephrology $91,582
Dr. Haimanot Wasse, Md, Mph, MD, MPH
Nephrology — Payments: $74,835
Nephrology $74,835
Tarik Lalwani, Md, MD
Nephrology — Payments: $64,361
Nephrology $64,361
Janice Lea, M.d, M.D
Nephrology — Payments: $35,190
Nephrology $35,190
Dr. Elizabeth Nguyen, M.d, M.D
Nephrology — Payments: $33,926
Nephrology $33,926